Viewing Study NCT00500903


Ignite Creation Date: 2025-12-24 @ 7:45 PM
Ignite Modification Date: 2026-01-24 @ 7:29 AM
Study NCT ID: NCT00500903
Status: COMPLETED
Last Update Posted: 2019-03-14
First Post: 2007-07-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of MLN8237, a Novel Aurora A Kinase Inhibitor, in Participants With Advanced Solid Tumors
Sponsor: Millennium Pharmaceuticals, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-05-15
Start Date Type: ACTUAL
Primary Completion Date: 2010-08-01
Primary Completion Date Type: ACTUAL
Completion Date: 2011-02-23
Completion Date Type: ACTUAL
First Submit Date: 2007-07-12
First Submit QC Date: None
Study First Post Date: 2007-07-13
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2018-01-04
Results First Submit QC Date: None
Results First Post Date: 2019-03-14
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-11-29
Last Update Post Date: 2019-03-14
Last Update Post Date Type: ACTUAL